Juan W. Valle/LinkedIn
Jul 15, 2025, 10:55
Juan W. Valle: 2025 ESMO-GI Congress Highlights – The Latest Data on Hepatobiliary Cancers
Juan W. Valle, Chief Medical Officer at Cholangiocarcinoma Foundation, shared a post on LinkedIn:
“Join Us on Tuesday, July 15 for: Oncology Town Hall – 2025 ESMO-GI Congress Highlights: The Latest Data on Immune-Based Strategies Across Hepatobiliary Cancers.
Thanks to an educational grant from AstraZeneca and hosted in partnership with the Cholangiocarcinoma Foundation, this webinar is for professionals seeking to:
- Evaluate immune-based treatment strategies for advanced hepatobiliary cancers and their applicability to diverse patient populations, including those with hepatic dysfunction or poor performance status.
- Apply recent evidence to inform treatment selection, sequencing, and delivery of immunotherapy in hepatocellular and biliary tract cancers across frontline and emerging therapeutic settings.
- Evaluate strategies to improve coordination and delivery of care among patients with hepatobiliary cancers.
Learn more and register here.”
More posts featuring Juan W. Valle.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 15, 2025, 13:40
Jul 15, 2025, 13:20
Jul 15, 2025, 12:47
Jul 15, 2025, 10:49
Jul 15, 2025, 10:26
Jul 15, 2025, 10:20